These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM, Earls MF. Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [Abstract] [Full Text] [Related]
4. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Polanczyk G, Zeni C, Genro JP, Guimarães AP, Roman T, Hutz MH, Rohde LA. Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289 [Abstract] [Full Text] [Related]
5. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Avale ME, Falzone TL, Gelman DM, Low MJ, Grandy DK, Rubinstein M. Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433 [Abstract] [Full Text] [Related]
7. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder. Staller JA, Faraone SV. Expert Rev Neurother; 2007 Apr; 7(4):351-62. PubMed ID: 17425490 [Abstract] [Full Text] [Related]
12. Attention deficit/hyperactivity disorder in adults. Moss SB, Nair R, Vallarino A, Wang S. Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755 [Abstract] [Full Text] [Related]